HSPA8 and Merkel cell skin cancer: Importantly, MAL3-101, an inhibitor of HSP70 ATPase activity, has been demonstrated to induce apoptosis in MCC cell lines and inhibit tumor growth in MCC xenograft model (Adam et al., 2014), suggesting that inhibition of HSP70/HSC70 activity can be a potential therapeutic strategy for MCC treatment.